Literature DB >> 22081584

Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis.

Clement L Ren1, Margaret Rosenfeld, Oscar H Mayer, Stephanie D Davis, Margaret Kloster, Robert G Castile, Peter W Hiatt, Meeghan Hart, Robin Johnson, Paul Jones, Lyndia C Brumback, Gwendolyn S Kerby.   

Abstract

OBJECTIVE: To analyze cross-sectional and longitudinal associations between lung function measures and clinical features in a cohort of preschool children with cystic fibrosis (CF).
METHODS: Longitudinal eight-center observational study of children with CF aged 36-60 months at enrollment, who underwent semiannual pulmonary function tests (PFTs) for up to 2 years consisting of spirometry (all 8 sites), forced oscillometry (FO, 5 sites), and measures of thoracoabdominal asynchrony using respiratory inductive plethysmography (IP, 5 sites).
RESULTS: Ninety-three subjects were enrolled; 181 acceptable spirometry measurements from 71 subjects, 128 FO from 47 subjects, and 142 IP from 50 subjects were available for analysis. Cross sectional analyses did not detect an association between any PFT parameter at enrollment and Pseudomonas aeruginosa (Pa) status, CF gene mutation class, Wisconsin cough score, Shwachman score, environmental tobacco smoke exposure, family history of asthma, or nutritional indices. In longitudinal analyses, Pa infection within 6 months preceding enrollment was associated with a significantly greater rate of decline in z-scores for forced expiratory flow between 25 and 75% of forced vital capacity (FEF(25-75) ) (-1.3 vs. -0.4 Z scores/year, P = 0.024) and greater thoracoabdominal asynchrony measured by IP (mean phase angle difference 4.6°, P = 0.004). No other significant longitudinal associations were observed.
CONCLUSIONS: Prior Pa infection is associated with a greater rate of decline in FEF(25-75) z-score and mild thoracoabdominal asynchrony in preschool children with CF. In this multicenter US study, significant associations between other lung function measures and clinical features were not detected.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081584     DOI: 10.1002/ppul.21590

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  11 in total

1.  Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.

Authors:  Weili Li; David Soave; Melissa R Miller; Katherine Keenan; Fan Lin; Jiafen Gong; Theodore Chiang; Anne L Stephenson; Peter Durie; Johanna Rommens; Lei Sun; Lisa J Strug
Journal:  Hum Genet       Date:  2013-09-22       Impact factor: 4.132

2.  Early pulmonary disease manifestations in cystic fibrosis mice.

Authors:  Rebecca J Darrah; Anna L Mitchell; Cara K Campanaro; Eric S Barbato; Paul Litman; Abdus Sattar; Craig A Hodges; Mitchell L Drumm; Frank J Jacono
Journal:  J Cyst Fibros       Date:  2016-05-24       Impact factor: 5.482

Review 3.  Lung Function Assessment by Impulse Oscillometry in Adults.

Authors:  Noemi Porojan-Suppini; Ovidiu Fira-Mladinescu; Monica Marc; Emanuela Tudorache; Cristian Oancea
Journal:  Ther Clin Risk Manag       Date:  2020-11-26       Impact factor: 2.423

4.  "Reactance inversion" at low frequencies in a child undergoing treatment of a cystic fibrosis exacerbation.

Authors:  Julian Lewis Allen; Clement L Ren; Joseph McDonough; Charles C Clem
Journal:  Pediatr Investig       Date:  2019-12-21

5.  Association of lung function, chest radiographs and clinical features in infants with cystic fibrosis.

Authors:  Margaret Rosenfeld; Philip M Farrell; Margaret Kloster; Jonathan O Swanson; Thuy Vu; Lyndia Brumback; James D Acton; Robert G Castile; Andrew A Colin; Carol K Conrad; Meeghan A Hart; Gwendolyn S Kerby; Peter W Hiatt; Peter J Mogayzel; Robin C Johnson; Stephanie D Davis
Journal:  Eur Respir J       Date:  2013-05-30       Impact factor: 16.671

6.  Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis.

Authors:  Laura A McCauley; William Thomas; Theresa A Laguna; Warren E Regelmann; Antoinette Moran; Lynda E Polgreen
Journal:  Ann Am Thorac Soc       Date:  2014-02

7.  AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations.

Authors:  Rebecca J Darrah; Frank J Jacono; Neha Joshi; Anna L Mitchell; Abdus Sattar; Cara K Campanaro; Paul Litman; Jennifer Frey; David E Nethery; Eric S Barbato; Craig A Hodges; Harriet Corvol; Garry R Cutting; Michael R Knowles; Lisa J Strug; Mitchell L Drumm
Journal:  J Cyst Fibros       Date:  2018-06-22       Impact factor: 5.482

Review 8.  Oscillometry of the respiratory system: a translational opportunity not to be missed.

Authors:  Lennart K A Lundblad; Annette Robichaud
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-06       Impact factor: 5.464

9.  Tidal Breathing Measurements at Discharge and Clinical Outcomes in Extremely Low Gestational Age Neonates.

Authors:  Clement L Ren; Rui Feng; Stephanie D Davis; Eric Eichenwald; Alan Jobe; Paul E Moore; Howard B Panitch; Jack K Sharp; Jeff Kisling; Charles Clem; James S Kemp
Journal:  Ann Am Thorac Soc       Date:  2018-11

Review 10.  The Impact of Secondhand Smoke Exposure on Children with Cystic Fibrosis: A Review.

Authors:  Benjamin T Kopp; Juan Antonio Ortega-García; S Christy Sadreameli; Jack Wellmerling; Estelle Cormet-Boyaka; Rohan Thompson; Sharon McGrath-Morrow; Judith A Groner
Journal:  Int J Environ Res Public Health       Date:  2016-10-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.